Obesity can cause insulin resistance and can increase the risk of type 2 diabetes. A person can not lower the body weight with a metformin, which is an important diabetes drug currently available. So additional therapies are required to lower the body weight.
A study shows that the acupuncture, an alternative therapy, can be performed along with metformin to lower the body weight. The weight loss can cause an improvement in the insulin sensitivity, significant changes in the leptin levels and an improvement in the BMI/blood sugar/cholesterol levels. The researchers concluded that the acupuncture is an insulin sensitizer and can improve the insulin sensitivity.
The depression is affecting about 25 percent of the patients of type 2 diabetes (T2D). A study found that there was a decreased depression score with the lifestyle interventions. Face to face consultation is the most effective way to improve the depression score. Once a week consultation will be more effective. The study was published in the Psychiatric Services.
The weight of the body increases if you sit and work for a longer period. An earlier study shows that health risks such as heart failure and disability are directly proportional to the sitting time and indirectly proportional to the life expectancy.
A person can use a sit-stand desk to lower the sitting time while working. A person can also use a treadmill desk. The author of the study says that the prolonged standing at the workplace can also worsen the health as it will enlarge your arteries. The author of the study was Dr. Jos Verbeek, a health researcher.
FDA warned that the use of Invokana (canagliflozin) could increase the risk of leg and foot amputations. Invokana (canagliflozin) is an SGLT2 inhibitor. It helps in filtering out sugar (glucose) from the blood and allow it to leave our body through urine.
But the use of Invokana causes a double risk of amputation when compared with placebo. Patients are advised to seek an immediate medical attention if they are experiencing a complication.
The researchers from the German Center for Diabetes Research (DZD) says that the factors such as fatty liver, visceral fat and impaired insulin secretion/action of the insulin may give a better indication of the cardiometabolic risk in a person.
The researchers say that the above four factors should be considered for the prevention and treatment of diabetes and other diseases. The study was reported in the Lancet Diabetes and Endocrinology.
A patient of type 1 or type 2 (T1D or T2D) diabetes may experience an increase in the blood sugar (glucose) levels during the physical or mental stress as the stress hormones may directly affect the blood sugar (glucose) levels. This may happen even if the patient is sick or injured.
So the best way to lower the blood sugar levels is to control all form of stress - mental, emotional, physical, family and work stresses.
Veteran IndyCar racer Charlie Kimball, a patient of type 1 diabetes since 2007, says he is using a new medication called Tresiba. He is taking one injection per day to control his type 1 diabetes (T1D).
Obesity and type 2 diabetes (T2D) is the deadly combination. A new guideline by Dr. David Cummings says that the weight loss surgery is a better treatment option for an obese patient of diabetes. His views have been endorsed by the American Diabetes Association and the other health groups.
But the surgery is also recommended to poorly controlled patients of diabetes even if the BMI is 35 or more. The bariatric surgery (metabolic surgery) will be performed on the patients to control diabetes as the risk of death or side effects are minimum. The new guidelines were published in the journal Diabetes Care.
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. The published article is not medical advice by the OWNER of the "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.